Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Characterization of Intestinal Hormone and Glucose Dynamics to Unravel the Antidiabetic Effect of Bariatric Surgery

NCT04712409 is registered in ClinicalTrials.gov with Hospital de Sao Sebastiao as lead sponsor.

NCT NCT04712409
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04712409 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Characterization of Intestinal Hormone and Glucose Dynamics to Unravel the Antidiabetic Effect of Bariatric Surgery
Lead sponsor
Hospital de Sao Sebastiao
Phase
Not applicable
Overall status
Unknown status
Start date
August 16, 2020
Completion date
February 1, 2025
Enrollment
40 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

determine whether bpd with ds or sadi-s as primary or revisional surgery is superior than the other as first choice for the superobese, determine whether or not revision surgery is as effective as primary surgery and understand the physiological mechanisms inherent in these putative differences, enteroendocrine physiological changes in superobese patients submitted to two different bariatric procedures